This federal contract award is for the pharmaceutical product Ozempic 2 mg/dose (8 mg/3 ml), 3 ml, with a $5,184.48 ceiling value and a July 2, 2024 award date. The contract, which has a July 3, 2024 ultimate completion date, was awarded to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA), a defense agency.
The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.
Generated 10/1/24, 11:39 AM